Skip to main content
Top
Published in: Drugs 12/2013

01-08-2013 | Review Article

Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Diagnosis and Treatment

Authors: Christopher Hom, Michael F. Vaezi

Published in: Drugs | Issue 12/2013

Login to get access

Abstract

Gastroesophageal reflux disease (GERD) is a common disease that is often diagnosed based on typical symptoms of heartburn and regurgitation. In addition to these more classic manifestations, GERD is increasingly associated with extra-esophageal symptoms, including chronic cough, asthma, laryngitis, and dental erosions. Due to the poor sensitivity of endoscopy and pH monitoring, and the poor specificity of laryngoscopy, empiric therapy with proton pump inhibitors (PPIs) is now considered the initial diagnostic step in patients suspected of having GERD-related symptoms. For those who improve with PPIs, GERD is the presumed etiology, but for those who remain unresponsive to such therapy, further diagnostic testing with impedance/pH monitoring may be necessary in order to exclude refractory acid or weakly acid reflux. In those with normal test results despite PPI therapy and continued symptoms, causes other than GERD may be pursued. Recent data suggest that in patients with extra-esophageal symptoms, objective findings of moderate-sized hiatal hernia and moderate reflux on pH testing may predict response to acid suppressive therapy. PPI-unresponsive patients usually have causes other than GERD for their extra-esophageal symptoms and continued PPI therapy in this group is not recommended.
Literature
1.
go back to reference Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943). Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943).
2.
go back to reference Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:29–37.PubMed Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:29–37.PubMed
3.
go back to reference Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.PubMedCrossRef Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.PubMedCrossRef
4.
go back to reference Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol. 2005;100:759–65.PubMedCrossRef Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol. 2005;100:759–65.PubMedCrossRef
5.
go back to reference Berstad T. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: surgical treatment. Scand J Gastroenterol Suppl. 1995;211:26–8.PubMedCrossRef Berstad T. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: surgical treatment. Scand J Gastroenterol Suppl. 1995;211:26–8.PubMedCrossRef
6.
go back to reference Cicala M, Emerenziani S, Caviglia R, et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;18:605–13.PubMedCrossRef Cicala M, Emerenziani S, Caviglia R, et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;18:605–13.PubMedCrossRef
7.
8.
go back to reference Shaw GY. Application of ambulatory 24-hour multiprobe pH monitoring in the presence of extraesophageal manifestations of gastroesophageal reflux. Ann Otol Rhinol Laryngol Suppl. 2000;184:15–7.PubMed Shaw GY. Application of ambulatory 24-hour multiprobe pH monitoring in the presence of extraesophageal manifestations of gastroesophageal reflux. Ann Otol Rhinol Laryngol Suppl. 2000;184:15–7.PubMed
9.
go back to reference Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943). Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943).
10.
go back to reference Fenter TC, Naslund MJ, Shah MB, et al. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care. 2006;12:S90–8.PubMed Fenter TC, Naslund MJ, Shah MB, et al. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care. 2006;12:S90–8.PubMed
11.
go back to reference Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11.PubMedCrossRef Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11.PubMedCrossRef
12.
go back to reference Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136:376–86.PubMedCrossRef Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136:376–86.PubMedCrossRef
13.
go back to reference Francis DO, Rymer JA, Slaughter JC, Choksi Y, Jiramongkolchai P, Ogbeide E, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013 Jun;108(6):905-11 Francis DO, Rymer JA, Slaughter JC, Choksi Y, Jiramongkolchai P, Ogbeide E, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013 Jun;108(6):905-11
14.
go back to reference Field SK, Evans JA, Price LM. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med. 1998;157:1058–62.PubMedCrossRef Field SK, Evans JA, Price LM. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med. 1998;157:1058–62.PubMedCrossRef
15.
go back to reference Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med. 1994;149:160–7.PubMedCrossRef Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med. 1994;149:160–7.PubMedCrossRef
16.
go back to reference Adhami T, Goldblum JR, Richter JE, et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99:2098–106.PubMedCrossRef Adhami T, Goldblum JR, Richter JE, et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99:2098–106.PubMedCrossRef
17.
go back to reference Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology. 1984;87:872–81.PubMed Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology. 1984;87:872–81.PubMed
18.
19.
go back to reference Shaker R. Protective mechanisms against supraesophageal GERD. J Clin Gastroenterol. 2000;30:S3–8.PubMedCrossRef Shaker R. Protective mechanisms against supraesophageal GERD. J Clin Gastroenterol. 2000;30:S3–8.PubMedCrossRef
20.
go back to reference Jadcherla SR, Gupta A, Coley BD, et al. Esophago-glottal closure reflex in human infants: a novel reflex elicited with concurrent manometry and ultrasonography. Am J Gastroenterol. 2007;102:2286–93.PubMedCrossRef Jadcherla SR, Gupta A, Coley BD, et al. Esophago-glottal closure reflex in human infants: a novel reflex elicited with concurrent manometry and ultrasonography. Am J Gastroenterol. 2007;102:2286–93.PubMedCrossRef
21.
go back to reference Jaspersen D. Extra-esophageal disorders in gastroesophageal reflux disease. Dig Dis. 2004;22:115–9.PubMedCrossRef Jaspersen D. Extra-esophageal disorders in gastroesophageal reflux disease. Dig Dis. 2004;22:115–9.PubMedCrossRef
22.
go back to reference Malagelada JR. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;19(Suppl 1):43–8.PubMedCrossRef Malagelada JR. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;19(Suppl 1):43–8.PubMedCrossRef
23.
24.
go back to reference Paterson WG. Extraesophageal complications of gastroesophageal reflux disease. Can J Gastroenterol. 1997;11(Suppl B):45B–50B. Paterson WG. Extraesophageal complications of gastroesophageal reflux disease. Can J Gastroenterol. 1997;11(Suppl B):45B–50B.
25.
go back to reference Paterson WG. Extraesophageal manifestations of reflux disease: myths and reality. Chest Surg Clin N Am. 2001;11:523–38.PubMed Paterson WG. Extraesophageal manifestations of reflux disease: myths and reality. Chest Surg Clin N Am. 2001;11:523–38.PubMed
26.
go back to reference Vaezi MF. Chronic cough and gastroesophageal reflux disease: how do we establish a causal link? Chest. 2013;143:587–9.PubMedCrossRef Vaezi MF. Chronic cough and gastroesophageal reflux disease: how do we establish a causal link? Chest. 2013;143:587–9.PubMedCrossRef
27.
go back to reference Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology. 1990;99:71–3.PubMed Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology. 1990;99:71–3.PubMed
28.
go back to reference Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333–44.PubMedCrossRef Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333–44.PubMedCrossRef
29.
go back to reference Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med. 2000;108(Suppl 4a):112S–119S. Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med. 2000;108(Suppl 4a):112S–119S.
30.
go back to reference Poe RH, Kallay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest. 2003;123:679–84.PubMedCrossRef Poe RH, Kallay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest. 2003;123:679–84.PubMedCrossRef
31.
go back to reference Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:80S–94S.PubMedCrossRef Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:80S–94S.PubMedCrossRef
32.
go back to reference Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin. 2005;15:323–33.PubMedCrossRef Kahrilas PJ, Lee TJ. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin. 2005;15:323–33.PubMedCrossRef
33.
go back to reference Chang AB, Lasserson TJ, Gaffney J, et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2005;(2):CD004823. Chang AB, Lasserson TJ, Gaffney J, et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2005;(2):CD004823.
34.
go back to reference Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011;13:213–8.PubMedCrossRef Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011;13:213–8.PubMedCrossRef
35.
go back to reference Vaezi MF. Therapy insight: gastroesophageal reflux disease and laryngopharyngeal reflux. Nat Clin Pract Gastroenterol Hepatol. 2005;2:595–603.PubMedCrossRef Vaezi MF. Therapy insight: gastroesophageal reflux disease and laryngopharyngeal reflux. Nat Clin Pract Gastroenterol Hepatol. 2005;2:595–603.PubMedCrossRef
36.
go back to reference Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–56.PubMedCrossRef Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–56.PubMedCrossRef
37.
go back to reference Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–14.PubMed Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905–14.PubMed
38.
go back to reference Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol. 1997;92:2160–5.PubMed Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol. 1997;92:2160–5.PubMed
39.
go back to reference Vaezi MF. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests? Am J Gastroenterol. 2004;99:786–8.PubMedCrossRef Vaezi MF. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests? Am J Gastroenterol. 2004;99:786–8.PubMedCrossRef
40.
go back to reference Metz DC, Childs ML, Ruiz C, et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg. 1997;116:41–6.PubMedCrossRef Metz DC, Childs ML, Ruiz C, et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg. 1997;116:41–6.PubMedCrossRef
41.
go back to reference Diamond L. Laryngopharyngeal reflux—it’s not GERD. JAAPA. 2005;18:50–3.PubMed Diamond L. Laryngopharyngeal reflux—it’s not GERD. JAAPA. 2005;18:50–3.PubMed
42.
go back to reference Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559–63.PubMedCrossRef Samuels TL, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg. 2009;141:559–63.PubMedCrossRef
43.
go back to reference Johnston N, Dettmar PW, Bishwokarma B, et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036–9.PubMedCrossRef Johnston N, Dettmar PW, Bishwokarma B, et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036–9.PubMedCrossRef
44.
go back to reference Wood JM, Hussey DJ, Woods CM, et al. Biomarkers and laryngopharyngeal reflux. J Laryngol Otol. 2011;125:1218–24.PubMedCrossRef Wood JM, Hussey DJ, Woods CM, et al. Biomarkers and laryngopharyngeal reflux. J Laryngol Otol. 2011;125:1218–24.PubMedCrossRef
45.
go back to reference Johnston N, Wells CW, Blumin JH, et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116:934–8.PubMed Johnston N, Wells CW, Blumin JH, et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116:934–8.PubMed
46.
go back to reference Bardhan KD, Strugala V, Dettmar PW. Reflux revisited: advancing the role of pepsin. Int J Otolaryngol. 2012;2012:646901.PubMed Bardhan KD, Strugala V, Dettmar PW. Reflux revisited: advancing the role of pepsin. Int J Otolaryngol. 2012;2012:646901.PubMed
47.
go back to reference Vaezi MF, Slaughter JC, Smith BS, et al. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther. 2010;32:916–24.PubMedCrossRef Vaezi MF, Slaughter JC, Smith BS, et al. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther. 2010;32:916–24.PubMedCrossRef
48.
go back to reference Kendall KA. Controversies in the diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14:113–5.PubMedCrossRef Kendall KA. Controversies in the diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14:113–5.PubMedCrossRef
49.
go back to reference Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice. 2002;16:564–79.PubMedCrossRef Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice. 2002;16:564–79.PubMedCrossRef
50.
go back to reference Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope. 2005;115:2256–61.PubMedCrossRef Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope. 2005;115:2256–61.PubMedCrossRef
51.
go back to reference Vavricka SR, Storck CA, Wildi SM, et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol. 2007;102:716–22.PubMedCrossRef Vavricka SR, Storck CA, Wildi SM, et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol. 2007;102:716–22.PubMedCrossRef
52.
go back to reference Richter JE. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am. 1996;25:75–102.PubMedCrossRef Richter JE. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am. 1996;25:75–102.PubMedCrossRef
53.
go back to reference Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone. 2003;5:32–8 (discussion 39–40). Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone. 2003;5:32–8 (discussion 39–40).
54.
go back to reference Joniau S, Bradshaw A, Esterman A, et al. Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg. 2007;136:686–92.PubMedCrossRef Joniau S, Bradshaw A, Esterman A, et al. Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg. 2007;136:686–92.PubMedCrossRef
55.
56.
go back to reference Tutuian R, Castell DO. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med. 2003;115(Suppl 3A):119S–123S. Tutuian R, Castell DO. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med. 2003;115(Suppl 3A):119S–123S.
57.
go back to reference Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92:825–9.PubMed Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92:825–9.PubMed
58.
go back to reference Carroll TL, Fedore LW, Aldahlawi MM. pH impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope. 2012;122:2473–81. Carroll TL, Fedore LW, Aldahlawi MM. pH impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope. 2012;122:2473–81.
59.
go back to reference Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006;93:1483–7.PubMedCrossRef Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006;93:1483–7.PubMedCrossRef
60.
go back to reference Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.PubMedCrossRef Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.PubMedCrossRef
61.
go back to reference Vaezi MF, Hicks DM, Ours TM, et al. ENT manifestation of GERD: a large prospective study assessing treatment outcome and predictors of response [abstract]. Gastroenterology. 2001;120:A636. Vaezi MF, Hicks DM, Ours TM, et al. ENT manifestation of GERD: a large prospective study assessing treatment outcome and predictors of response [abstract]. Gastroenterology. 2001;120:A636.
62.
go back to reference Vaezi MF. Laryngitis: from the gastroenterologist’s point of view. In: Vaezi MF, editor. Extraesophageal reflux. San Diego: Plural Publishing, Inc.; 2009. p. 37–47. Vaezi MF. Laryngitis: from the gastroenterologist’s point of view. In: Vaezi MF, editor. Extraesophageal reflux. San Diego: Plural Publishing, Inc.; 2009. p. 37–47.
63.
go back to reference Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–8.PubMedCrossRef Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–8.PubMedCrossRef
64.
go back to reference Fletcher KC, Goutte M, Slaughter JC, Garrett CG, Vaezi MF. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope. 2011;121:2561–5. Fletcher KC, Goutte M, Slaughter JC, Garrett CG, Vaezi MF. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope. 2011;121:2561–5.
65.
go back to reference Wiener GJ, Tsukashima R,, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009;23:498–504. Wiener GJ, Tsukashima R,, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009;23:498–504.
66.
go back to reference Yuksel ES SJ, Mukhtar N, Ochieng M, Sun G, Goutte M, Garrett GC, Vaezi MF. An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis. Neurogastroenterol Motil. 2013 May;25(5):e315–23. Yuksel ES SJ, Mukhtar N, Ochieng M, Sun G, Goutte M, Garrett GC, Vaezi MF. An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis. Neurogastroenterol Motil. 2013 May;25(5):e315–23.
67.
go back to reference Sun G, Muddana S, Slaughter JC, et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope. 2009;119:1639–43.PubMedCrossRef Sun G, Muddana S, Slaughter JC, et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope. 2009;119:1639–43.PubMedCrossRef
68.
go back to reference Wiener GJ, Tsukashima R, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009;23:498–504.PubMedCrossRef Wiener GJ, Tsukashima R, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009;23:498–504.PubMedCrossRef
69.
go back to reference Potluri S, Friedenberg F, Parkman HP, et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig Dis Sci. 2003;48:1813–7.PubMedCrossRef Potluri S, Friedenberg F, Parkman HP, et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig Dis Sci. 2003;48:1813–7.PubMedCrossRef
70.
go back to reference Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.PubMedCrossRef Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.PubMedCrossRef
71.
go back to reference Ozmen S, Yucel OT, Sinici I, et al. Nasal pepsin assay and pH monitoring in chronic rhinosinusitis. Laryngoscope. 2008;118:890–4.PubMedCrossRef Ozmen S, Yucel OT, Sinici I, et al. Nasal pepsin assay and pH monitoring in chronic rhinosinusitis. Laryngoscope. 2008;118:890–4.PubMedCrossRef
72.
go back to reference Printza A, Speletas M, Triaridis S, et al. Is pepsin detected in the saliva of patients who experience pharyngeal reflux? Hippokratia. 2007;11:145–9.PubMed Printza A, Speletas M, Triaridis S, et al. Is pepsin detected in the saliva of patients who experience pharyngeal reflux? Hippokratia. 2007;11:145–9.PubMed
73.
go back to reference Kim TH, Lee KJ, Yeo M, et al. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion. 2008;77:201–6.PubMedCrossRef Kim TH, Lee KJ, Yeo M, et al. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion. 2008;77:201–6.PubMedCrossRef
74.
go back to reference Strugala V, McGlashan JA, Watson MG, Morice AH, Granier B, Dettmar PW. Detection of pepsin using a non-invasive lateral flow test for the diagnosis of extra-esophageal reflux—results of a pilot study [abstract]. Gut. 2007;56:A212. Strugala V, McGlashan JA, Watson MG, Morice AH, Granier B, Dettmar PW. Detection of pepsin using a non-invasive lateral flow test for the diagnosis of extra-esophageal reflux—results of a pilot study [abstract]. Gut. 2007;56:A212.
75.
go back to reference Saritas Yuksel E, Hong SK, Strugala V, Slaughter JC, Goutte M, Garrett CG, et al. Rapid salivary pepsin test: blinded assessment of test performance in GERD. Laryngoscope. 2012;122:1312–6. Saritas Yuksel E, Hong SK, Strugala V, Slaughter JC, Goutte M, Garrett CG, et al. Rapid salivary pepsin test: blinded assessment of test performance in GERD. Laryngoscope. 2012;122:1312–6.
76.
go back to reference Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115:1230–8.PubMedCrossRef Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115:1230–8.PubMedCrossRef
77.
go back to reference Williams RB, Szczesniak MM, Maclean JC, et al. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol. 2004;99:777–85.PubMedCrossRef Williams RB, Szczesniak MM, Maclean JC, et al. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol. 2004;99:777–85.PubMedCrossRef
78.
go back to reference Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006;116:254–60.PubMedCrossRef Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006;116:254–60.PubMedCrossRef
79.
go back to reference Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101:2646–54.PubMedCrossRef Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101:2646–54.PubMedCrossRef
80.
go back to reference Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011;121:1902–9.PubMedCrossRef Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011;121:1902–9.PubMedCrossRef
81.
go back to reference Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006;4:433–41.PubMedCrossRef Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006;4:433–41.PubMedCrossRef
82.
go back to reference Ours TM, Kavuru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94:3131–8.PubMedCrossRef Ours TM, Kavuru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94:3131–8.PubMedCrossRef
83.
go back to reference Baldi F, Cappiello R, Cavoli C, et al. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol. 2006;12:82–8.PubMed Baldi F, Cappiello R, Cavoli C, et al. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol. 2006;12:82–8.PubMed
84.
go back to reference Xiao Y, Carson D, Boris L, et al. The acoustic cough monitoring and manometric profile of cough and throat clearing. Dis Esophagus. 2013 Feb 26. doi:10.1111/dote.12038. [Epub ahead of print]. Xiao Y, Carson D, Boris L, et al. The acoustic cough monitoring and manometric profile of cough and throat clearing. Dis Esophagus. 2013 Feb 26. doi:10.​1111/​dote.​12038. [Epub ahead of print].
85.
go back to reference Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981;123:413–7.PubMed Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981;123:413–7.PubMed
86.
go back to reference Ludviksdottir D, Bjornsson E, Janson C, et al. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest. 1996;109:1262–8.PubMedCrossRef Ludviksdottir D, Bjornsson E, Janson C, et al. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest. 1996;109:1262–8.PubMedCrossRef
87.
go back to reference Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest. 2002;121:158–63.PubMedCrossRef Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest. 2002;121:158–63.PubMedCrossRef
88.
go back to reference el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113:755–60. el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113:755–60.
89.
go back to reference Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. 2005;54:1492–9.PubMedCrossRef Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. 2005;54:1492–9.PubMedCrossRef
90.
go back to reference Alhabib KF, Vedal S, Champion P, et al. The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma. Can J Gastroenterol. 2007;21:159–63.PubMed Alhabib KF, Vedal S, Champion P, et al. The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma. Can J Gastroenterol. 2007;21:159–63.PubMed
91.
go back to reference Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut. 2005;54:449–54.PubMedCrossRef Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut. 2005;54:449–54.PubMedCrossRef
92.
go back to reference Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful response to specific therapy. Am Rev Respir Dis. 1981;123(4 Pt 1):413–7. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful response to specific therapy. Am Rev Respir Dis. 1981;123(4 Pt 1):413–7.
93.
go back to reference Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143:605–12. Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143:605–12.
94.
95.
go back to reference Laukka MA, Cameron AJ, Schei AJ. Gastroesophageal reflux and chronic cough: which comes first? J Clin Gastroenterol. 1994;19:100–4.PubMedCrossRef Laukka MA, Cameron AJ, Schei AJ. Gastroesophageal reflux and chronic cough: which comes first? J Clin Gastroenterol. 1994;19:100–4.PubMedCrossRef
96.
go back to reference Lacy BE, Weiser K, Chertoff J, et al. The diagnosis of gastroesophageal reflux disease. Am J Med. 2010;123:583–92.PubMedCrossRef Lacy BE, Weiser K, Chertoff J, et al. The diagnosis of gastroesophageal reflux disease. Am J Med. 2010;123:583–92.PubMedCrossRef
97.
go back to reference Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008;135:756–69.PubMedCrossRef Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008;135:756–69.PubMedCrossRef
98.
go back to reference Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–98.PubMedCrossRef Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–98.PubMedCrossRef
99.
go back to reference Bredenoord AJ, Weusten BL, Timmer R, et al. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol. 2005;100:265–9.PubMedCrossRef Bredenoord AJ, Weusten BL, Timmer R, et al. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol. 2005;100:265–9.PubMedCrossRef
100.
go back to reference Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–74. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–74.
101.
go back to reference Paterson WG, Murat BW. Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough. Dig Dis Sci. 1994;39:1117–25.PubMedCrossRef Paterson WG, Murat BW. Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough. Dig Dis Sci. 1994;39:1117–25.PubMedCrossRef
102.
go back to reference Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107:1826–32.PubMedCrossRef Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107:1826–32.PubMedCrossRef
103.
go back to reference Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010;139:754–62.PubMedCrossRef Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010;139:754–62.PubMedCrossRef
104.
go back to reference Faruqi S, Molyneux ID, Fathi H, et al. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology. 2011;16:1150–6.PubMedCrossRef Faruqi S, Molyneux ID, Fathi H, et al. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology. 2011;16:1150–6.PubMedCrossRef
105.
go back to reference Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough—a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:225–34.PubMedCrossRef Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough—a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:225–34.PubMedCrossRef
106.
go back to reference Bastian RW, Vaidya AM, Delsupehe KG. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg. 2006;135:17–21.PubMedCrossRef Bastian RW, Vaidya AM, Delsupehe KG. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg. 2006;135:17–21.PubMedCrossRef
107.
go back to reference O’Connell F, Thomas VE, Pride NB, et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 1994;150:374–80.PubMedCrossRef O’Connell F, Thomas VE, Pride NB, et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 1994;150:374–80.PubMedCrossRef
108.
go back to reference Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol. 2005;114:253–7.PubMed Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol. 2005;114:253–7.PubMed
109.
go back to reference Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med. 2006;119:e13–5.PubMedCrossRef Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med. 2006;119:e13–5.PubMedCrossRef
110.
go back to reference Halum SL, Sycamore DL, McRae BR. A new treatment option for laryngeal sensory neuropathy. Laryngoscope. 2009;119:1844–7.PubMedCrossRef Halum SL, Sycamore DL, McRae BR. A new treatment option for laryngeal sensory neuropathy. Laryngoscope. 2009;119:1844–7.PubMedCrossRef
111.
go back to reference Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999;115:654–9.PubMedCrossRef Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999;115:654–9.PubMedCrossRef
112.
go back to reference Sontag SJ, O’Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99:613–20.PubMed Sontag SJ, O’Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99:613–20.PubMed
113.
go back to reference Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162:34–9.PubMedCrossRef Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162:34–9.PubMedCrossRef
114.
go back to reference Thomas JW. National Heart, Lung, and Blood Institute resources and programs for cell-based therapies. Circ Res. 2007;101:1–6.PubMedCrossRef Thomas JW. National Heart, Lung, and Blood Institute resources and programs for cell-based therapies. Circ Res. 2007;101:1–6.PubMedCrossRef
115.
go back to reference Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med. 2010;16:60–3.PubMedCrossRef Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med. 2010;16:60–3.PubMedCrossRef
116.
117.
go back to reference Zerbib F, Guisset O, Lamouliatte H, et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med. 2002;166:1206–11.PubMedCrossRef Zerbib F, Guisset O, Lamouliatte H, et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med. 2002;166:1206–11.PubMedCrossRef
118.
go back to reference Leggett JL, Johnston BT, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1227–31. Leggett JL, Johnston BT, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1227–31.
119.
go back to reference Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007;56:1654–64.PubMedCrossRef Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007;56:1654–64.PubMedCrossRef
120.
go back to reference Kiljander TO, Salomaa ER, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest. 1999;116:1257–64.PubMedCrossRef Kiljander TO, Salomaa ER, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest. 1999;116:1257–64.PubMedCrossRef
121.
go back to reference Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci. 1994;39:2127–33.PubMedCrossRef Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci. 1994;39:2127–33.PubMedCrossRef
122.
go back to reference Leggett JJ, Johnston BT, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1227–31.PubMedCrossRef Leggett JJ, Johnston BT, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1227–31.PubMedCrossRef
123.
go back to reference Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100:395–405.PubMedCrossRef Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100:395–405.PubMedCrossRef
124.
go back to reference Littner MR, Leung FW, Ballard ED 2nd, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128:1128–35.PubMedCrossRef Littner MR, Leung FW, Ballard ED 2nd, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128:1128–35.PubMedCrossRef
125.
go back to reference Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173:1091–7.PubMedCrossRef Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173:1091–7.PubMedCrossRef
126.
go back to reference Sontag SJ, O’Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol. 2003;98:987–99.PubMed Sontag SJ, O’Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol. 2003;98:987–99.PubMed
127.
go back to reference Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360:1487–99.PubMedCrossRef Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360:1487–99.PubMedCrossRef
128.
go back to reference Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma a randomized controlled trial. JAMA. 2012;307:373–81.PubMedCrossRef Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma a randomized controlled trial. JAMA. 2012;307:373–81.PubMedCrossRef
129.
go back to reference Gibson PG, Powell H, Coughlan J, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev. 2002;(2):CD001005. Gibson PG, Powell H, Coughlan J, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev. 2002;(2):CD001005.
Metadata
Title
Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Diagnosis and Treatment
Authors
Christopher Hom
Michael F. Vaezi
Publication date
01-08-2013
Publisher
Springer International Publishing
Published in
Drugs / Issue 12/2013
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-013-0101-8

Other articles of this Issue 12/2013

Drugs 12/2013 Go to the issue